Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$13.30
+7.5%
$10.88
$8.27
$30.10
$370.97M1.31628,055 shs737,068 shs
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$16.85
+0.1%
$0.00
$10.87
$18.79
$425.80MN/A115,778 shs154,266 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$10.33
-1.9%
$10.52
$8.12
$17.35
$363.51M0.54501,063 shs396,578 shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$9.79
-4.1%
$9.72
$7.15
$19.77
$100.65M1.45116,089 shs75,329 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-2.14%+4.65%+8.80%+38.37%+4.92%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
+19.26%+22.29%+1,683,999,900.00%+1,683,999,900.00%+1,683,999,900.00%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-0.66%-2.77%-2.50%+14.08%-35.40%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-3.22%-4.13%+7.47%+13.70%-46.29%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$13.30
+7.5%
$10.88
$8.27
$30.10
$370.97M1.31628,055 shs737,068 shs
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$16.85
+0.1%
$0.00
$10.87
$18.79
$425.80MN/A115,778 shs154,266 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$10.33
-1.9%
$10.52
$8.12
$17.35
$363.51M0.54501,063 shs396,578 shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$9.79
-4.1%
$9.72
$7.15
$19.77
$100.65M1.45116,089 shs75,329 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-2.14%+4.65%+8.80%+38.37%+4.92%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
+19.26%+22.29%+1,683,999,900.00%+1,683,999,900.00%+1,683,999,900.00%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-0.66%-2.77%-2.50%+14.08%-35.40%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-3.22%-4.13%+7.47%+13.70%-46.29%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$18.0035.34% Upside
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
0.00
N/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.43
Hold$22.50117.81% Upside
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2.40
Hold$15.2055.26% Upside

Current Analyst Ratings Breakdown

Latest LAKE, CLPT, DCTH, and CNXU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
UpgradeSell (D)Sell (D+)
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
DowngradeHoldStrong Sell
5/8/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Initiated CoverageBuy$16.00
4/20/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Reiterated RatingSell (D-)
4/20/2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Set Price Target$16.00
4/20/2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
UpgradeNeutralBuy$10.00 ➝ $14.00
4/17/2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Lower Price TargetBuy$16.00 ➝ $13.00
4/8/2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Lower Price TargetNeutral$14.00 ➝ $10.00
4/2/2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Lower Price TargetBuy$19.00 ➝ $16.00
3/18/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Boost Price TargetBuy$18.00 ➝ $20.00
3/5/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Lower Price TargetBuy$28.00 ➝ $18.00
(Data available from 6/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M10.79N/AN/A$0.99 per share13.43
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.18$0.05 per share201.44$3.15 per share3.28
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$192.65M0.50N/AN/A$13.17 per share0.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$1.01N/AN/AN/A-71.57%-140.96%-36.98%8/11/2026 (Estimated)
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,033.00N/AN/A0.62%0.51%0.46%8/5/2026 (Estimated)
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$25.31M-$2.58N/A8.74N/A-13.14%-9.57%-6.06%6/9/2026 (Estimated)

Latest LAKE, CLPT, DCTH, and CNXU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/9/2026Q1 2027
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$0.14N/AN/AN/A$47.36 millionN/A
5/13/2026Q1 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.28-$0.32-$0.04-$0.32$11.97 million$12.13 million
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million
3/17/2026Q4 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.27-$0.05-$0.27$10.40 million$10.41 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.090.93%N/AN/A 1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.63
5.79
4.88
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
11.24
10.33
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.24
3.53
1.36

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
3.35%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11029.99 million27.91 millionOptionable
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
425.27 millionN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.52 million27.84 millionOptionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2,6009.86 million9.53 millionOptionable

Recent News About These Companies

Lakeland Industries (LAKE) Projected to Post Earnings on Tuesday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$13.30 +0.93 (+7.52%)
Closing price 04:00 PM Eastern
Extended Trading
$13.36 +0.05 (+0.41%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Conexeu Sciences stock logo

Conexeu Sciences NASDAQ:CNXU

$16.85 +0.01 (+0.06%)
Closing price 04:00 PM Eastern
Extended Trading
$16.75 -0.10 (-0.59%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$10.33 -0.20 (-1.90%)
Closing price 04:00 PM Eastern
Extended Trading
$10.20 -0.13 (-1.21%)
As of 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Lakeland Industries stock logo

Lakeland Industries NASDAQ:LAKE

$9.79 -0.42 (-4.11%)
Closing price 04:00 PM Eastern
Extended Trading
$9.78 0.00 (-0.05%)
As of 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.